Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRTN
2001
DELISTED
Triton International Limited
TRTN
| $20.9M | ﹤0.01% |
398,489
-56,651
| -12% | -$3M |
|
2002
PUT
iShares US Real Estate ETF
IYR
$4.66B
| $20.8M | ﹤0.01% |
203,900
+175,000
| +606% | +$17.4M |
|
2003
Cable One
CABO
$227M
| $20.7M | ﹤0.01% |
10,845
+20
| +0.2% | +$36K |
|
|
CLDR
2004
DELISTED
Cloudera, Inc.
CLDR
| $20.7M | ﹤0.01% |
1,305,613
-1,384,886
| -51% | -$18.8M |
|
|
TA
2005
DELISTED
TravelCenters of America LLC
TA
| $20.7M | ﹤0.01% |
708,078
+8,048
| +1% | +$224K |
|
2006
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
| $20.7M | ﹤0.01% |
196,363
+57,498
| +41% | +$6.01M |
|
|
P
2007
Everpure Inc
P
$25.7B
| $20.7M | ﹤0.01% |
1,059,425
-89,843
| -8% | -$1.77M |
|
|
AIU
2008
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $20.7M | ﹤0.01% |
134,550
-10
| -0% | -$2.51K |
|
2009
PUT
Pinduoduo
PDD
$126B
| $20.7M | ﹤0.01% |
162,800
+56,200
| +53% | +$7.3M |
|
2010
QuidelOrtho
QDEL
$1.14B
| $20.7M | ﹤0.01% |
161,344
-302,492
| -65% | -$35.6M |
|
2011
PUT
ConocoPhillips
COP
$147B
| $20.7M | ﹤0.01% |
339,200
+123,500
| +57% | +$6.88M |
|
|
AYX
2012
DELISTED
Alteryx Inc
AYX
| $20.6M | ﹤0.01% |
239,829
-42,583
| -15% | -$3.48M |
|
2013
PUT
eBay
EBAY
$50.6B
| $20.6M | ﹤0.01% |
+292,700
| New | +$18.4M |
|
2014
CALL
Vertex Pharmaceuticals
VRTX
$121B
| $20.5M | ﹤0.01% |
101,900
-175,200
| -63% | -$36.6M |
|
2015
PUT
Coca-Cola
KO
$377B
| $20.5M | ﹤0.01% |
379,400
+195,900
| +107% | +$10.7M |
|
2016
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.75B
| $20.5M | ﹤0.01% |
+438,869
| New | +$20.3M |
|
2017
Leggett & Platt
LEG
$1.34B
| $20.5M | ﹤0.01% |
396,058
-24,924
| -6% | -$1.3M |
|
|
ZY
2018
DELISTED
Zymergen Inc. Common Stock
ZY
| $20.5M | ﹤0.01% |
+512,803
| New | +$20.2M |
|
2019
CALL
Nike
NKE
$61.9B
| $20.5M | ﹤0.01% |
132,600
+23,600
| +22% | +$3.18M |
|
|
ARGO
2020
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $20.5M | ﹤0.01% |
394,808
+129,970
| +49% | +$7M |
|
2021
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
| $20.4M | ﹤0.01% |
106,309
-100,100
| -48% | -$18M |
|
|
NSTG
2022
DELISTED
NanoString Technologies, Inc.
NSTG
| $20.4M | ﹤0.01% |
315,432
+26,133
| +9% | +$1.66M |
|
2023
Ascendis Pharma A/S
ASND
$16B
| $20.3M | ﹤0.01% |
154,171
+81,338
| +112% | +$10.8M |
|
|
KYNB
2024
Kyntra Bio
KYNB
$27.2M
| $20.3M | ﹤0.01% |
30,462
-5,689
| -16% | -$3.28M |
|
2025
Rogers Communications
RCI
$18.3B
| $20.3M | ﹤0.01% |
381,463
-40,555
| -10% | -$2.05M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.